Havas Pharma Agency Bastion Brands Begins Planned Leadership Succession

Why It Matters

The succession secures continuity for a fast‑growing specialist pharma agency, strengthening Havas’ position in the lucrative health‑care communications market and underscoring its push toward AI‑driven services.

Key Takeaways

• Dan King promoted to Managing Director of Bastion Brands.
• Founder Simon Davies steps down, will support Europe projects.
• Agency posted over 17% growth in 2025 under Havas.
• Bastion Brands serves top pharma clients like Sanofi, GSK, CSL.
• Focus on AI‑enabled, data‑fluent capabilities for client insights.

Pulse Analysis

The health‑care communications sector has become a battleground for agencies seeking to blend scientific rigor with creative storytelling. Havas Group’s acquisition of Bastion Brands in 2022 gave the global network a foothold in Australia’s specialist pharma market, where clients demand both regulatory compliance and compelling patient engagement. By integrating Bastion into its broader Havas Health Network, the firm has been able to leverage cross‑regional expertise, offering clients seamless global campaigns while preserving local insight.

Leadership continuity is critical in an industry where client relationships hinge on trust and deep domain knowledge. Simon Davies’ decision to step back after fourteen years coincides with a period of robust performance—Bastion Brands reported over 17% growth in 2025, outpacing many peers. Elevating Dan King, who has been with the agency since 2019 and already manages complex commercial programs, signals to clients that the agency’s strategic direction remains steady. This move also reassures pharma partners such as Sanofi, GSK and CSL that their long‑term projects will experience minimal disruption.

Looking ahead, Bastion Brands is positioning AI and data fluency at the core of its service offering. King highlighted plans to deploy responsible, privacy‑safe AI for insight mining, medical content workflows and performance optimisation. In a market where speed to market and evidence‑based decision‑making are paramount, such capabilities can translate into faster campaign iterations and more precise targeting. By marrying AI with its “Deliberately Different” creative ethos, Bastion aims to set a new benchmark for integrated health communications, reinforcing Havas’ broader ambition to be a leader in data‑driven, science‑focused advertising.